Don’t Call It Project Orbis: CoGenT Global Will Pilot Collaborative Review Of Gene Therapies

Levers
Pooling global forces to review gene therapies is 'another lever that we have to pull,' FDA's Peter Marks said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Cell & Gene Therapies

More from Advanced Technologies